Home > Insider Trading > Filing (0001209191-21-002603)

Filing Details

Accession Number:: 0001209191-21-002603
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-07 18:40:09
Reporting Period:: 2021-01-05

Accepted Time:: 2021-01-07 18:40:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1618756	Restaurant Brands International Inc.	QSR	Retail-Eating Places (5812)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1728874	Matthew Dunnigan	130 King Street West Suite 300 Toronto A6 M5X 1E1	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2021-01-05	45	$0.00	12,531	No	4	A	Direct
Common Shares	Disposition	2021-01-05	1,924	$58.95	10,607	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	25	$0.00	25	$0.00
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	599	$0.00	599	$0.00
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	19	$0.00	19	$0.00
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	61	$0.00	61	$0.00
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	932	$0.00	932	$0.00
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	67	$0.00	67	$0.00
Common Shares	Dividend Equivalent Rights	Acquisiton	2021-01-05	453	$0.00	453	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
318	No	4	A	Direct
8,410	No	4	A	Direct
211	No	4	A	Direct
481	No	4	A	Direct
7,401	No	4	A	Direct
316	No	4	A	Direct
2,138	No	4	A	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Option (right to buy)	$42.26		2025-03-05	30,000	30,000	Direct
Common Shares	Restricted Share Units	$0.00			2,593	2,593	Direct
Common Shares	Performance Share Units	$0.00	2021-02-26	2021-02-26	60,600	60,600	Direct
Common Shares	Option (right to buy)	$55.55	2022-02-24	2027-02-23	40,000	40,000	Direct
Common Shares	Option (right to buy)	$56.92	2022-05-05	2027-05-04	40,000	40,000	Direct
Common Shares	Option (right to buy)	$58.44	2023-02-23	2028-02-22	100,000	100,000	Direct
Common Shares	Restricted Share Units	$0.00			1,947	1,947	Direct
Common Shares	Restricted Share Units	$0.00			6,500	6,500	Direct
Common Shares	Performance Share Units	$0.00	2024-02-22	2024-02-22	100,000	100,000	Direct
Common Shares	Option (right to buy)	$66.31	2025-02-21	2030-02-20	50,000	50,000	Direct
Common Shares	Restricted Share Units	$0.00			7,385	7,385	Direct
Common Shares	Performance Share Units	$0.00	2025-02-21	2025-02-21	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-03-05	30,000	30,000	Direct
	2,593	2,593	Direct
2021-02-26	60,600	60,600	Direct
2027-02-23	40,000	40,000	Direct
2027-05-04	40,000	40,000	Direct
2028-02-22	100,000	100,000	Direct
	1,947	1,947	Direct
	6,500	6,500	Direct
2024-02-22	100,000	100,000	Direct
2030-02-20	50,000	50,000	Direct
	7,385	7,385	Direct
2025-02-21	50,000	50,000	Direct

Footnotes

Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award.
Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units.
These options are immediately exercisable.
Each restricted share unit represents a contingent right to receive one common share.
These restricted share units vest on December 31, 2021.
Each whole dividend equivalent right represents a contingent right to receive one common share.
These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate.
The shares reported represent an award of performance based restricted share units (the "2016 PBRSUs") granted to the Reporting Person. The 2016 PBRSUs had a three-year performance period beginning January 1, 2015 and ending December 31, 2018 and will vest 100% on February 26, 2021, which is the fifth anniversary of the grant date.
These dividend equivalent rights accrued on the 2016 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 PBRSUs to which they relate.
These restricted share units vest on December 31, 2022.
These dividend equivalent rights accrued on the 2018 restricted share unit award (the "2018 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2018 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2018 RSUs to which they relate.
These restricted share units vest on December 31, 2023.
These dividend equivalent rights accrued on the 2019 restricted share unit award (the "2019 RSUs"). Dividend equivalent rights accrue whenand as dividends are paid on the common shares underlying the 2019 RSUs and vest proportionately with and are subject to settlement andexpiration upon the same terms as the 2019 RSUs to which they relate.
The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest 100% on February 22, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the Issuer performance condition.
Each whole dividend equivalent right represents a contingent right to receive one common share, subject to increase or decrease based on the results of the Issuer performance condition.
These dividend equivalent rights accrued on the 2019 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 PBRSUs to which they relate.
These restricted share units vest on December 31, 2024.
These dividend equivalent rights accrued on the 2020 restricted share unit award (the "2020 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020 RSUs to which they relate.
The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest 100% on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
These dividend equivalent rights accrued on the 2020 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020 PBRSUs to which they relate.